ARS Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Buy
58,958
+443
+0.8% +$103K 0.65% 38
2026
Q1
$14.3M Buy
58,515
+1,536
+3% +$358K 0.74% 35
2025
Q4
$11.8M Buy
56,979
+7,725
+16% +$1.53M 0.69% 39
2025
Q3
$9.13M Sell
49,254
-166
-0.3% -$28.4K 0.6% 40
2025
Q2
$7.55M Buy
49,420
+1,270
+3% +$195K 0.55% 40
2025
Q1
$6.96M Sell
48,150
-955
-2% -$149K 0.63% 40
2024
Q4
$7.1M Sell
49,105
-3,139
-6% -$486K 0.64% 40
2024
Q3
$8.47M Sell
52,244
-1,365
-3% -$217K 0.76% 39
2024
Q2
$7.84M Buy
53,609
+5,182
+11% +$771K 0.75% 37
2024
Q1
$7.66M Buy
48,427
+664
+1% +$106K 0.76% 37
2023
Q4
$7.49M Buy
47,763
+3,524
+8% +$540K 0.83% 34
2023
Q3
$6.89M Buy
44,239
+822
+2% +$136K 0.85% 36
2023
Q2
$7.19M Buy
43,417
+35,498
+448% +$5.73M 0.84% 35
2023
Q1
$1.23M Buy
7,919
+723
+10% +$117K 0.15% 74
2022
Q4
$1.27M Sell
7,196
-1,904
-21% -$329K 0.17% 68
2022
Q3
$1.49M Buy
9,100
+1,334
+17% +$226K 0.2% 65
2022
Q2
$1.38M Buy
7,766
+295
+4% +$52.6K 0.19% 65
2022
Q1
$1.32M Hold
7,471
0.13% 78
2021
Q4
$1.28M Sell
7,471
-38,022
-84% -$6.22M 0.12% 77
2021
Q3
$7.35M Sell
45,493
-1,642
-3% -$280K 0.74% 42
2021
Q2
$7.76M Buy
47,135
+1,016
+2% +$168K 0.79% 37
2021
Q1
$7.58M Buy
46,119
+710
+2% +$115K 0.88% 35
2020
Q4
$7.15M Sell
45,409
-37,524
-45% -$5.54M 0.88% 33
2020
Q3
$12.3M Buy
82,933
+546
+0.7% +$80.8K 1.94% 14
2020
Q2
$11.6M Buy
+82,387
New +$12M 2.18% 14
2020
Q1
Sell
-7,227
Closed -$1.05M 101
2019
Q4
$1.05M Sell
7,227
-9,851
-58% -$1.34M 0.18% 68
2019
Q3
$2.21M Sell
17,078
-5,022
-23% -$662K 0.4% 49
2019
Q2
$3.08M Buy
22,100
+3,979
+22% +$551K 0.52% 46
2019
Q1
$2.53M Sell
18,121
-1,397
-7% -$187K 0.46% 45
2018
Q4
$2.52M Buy
19,518
+328
+2% +$45.8K 0.53% 42
2018
Q3
$2.65M Buy
19,190
+299
+2% +$39.7K 0.41% 47
2018
Q2
$2.29M Sell
18,891
-103
-0.5% -$12.8K 0.37% 49
2018
Q1
$2.43M Sell
18,994
-292
-2% -$39.5K 0.3% 57
2017
Q4
$2.69M Sell
19,286
-725
-4% -$101K 0.33% 58
2017
Q3
$2.6M Sell
20,011
-4,362
-18% -$578K 0.34% 58
2017
Q2
$3.22M Sell
24,373
-550
-2% -$70.2K 0.45% 55
2017
Q1
$3.1M Sell
24,923
-766
-3% -$91.5K 0.45% 55
2016
Q4
$2.96M Sell
25,689
-6,498
-20% -$751K 0.46% 57
2016
Q3
$3.8M Sell
32,187
-5
-0% -$607 0.83% 44
2016
Q2
$3.9M Sell
32,192
-1,078
-3% -$122K 0.87% 44
2016
Q1
$3.6M Buy
33,270
+953
+3% +$98.7K 0.84% 42
2015
Q4
$3.32M Buy
32,317
+6,180
+24% +$621K 0.78% 45
2015
Q3
$2.44M Buy
26,137
+85
+0.3% +$8.22K 0.56% 56
2015
Q2
$2.54M Sell
26,052
-6,940
-21% -$695K 0.46% 60
2015
Q1
$3.32M Sell
32,992
-1,853
-5% -$188K 0.62% 51
2014
Q4
$3.64M Buy
34,845
+325
+0.9% +$34.2K 0.62% 53
2014
Q3
$3.68M Buy
34,520
+3,170
+10% +$329K 0.56% 51
2014
Q2
$3.28M Sell
31,350
-121
-0.4% -$12.2K 0.51% 55
2014
Q1
$3.09M Sell
31,471
-3,772
-11% -$350K 0.55% 55
2013
Q4
$3.23M Sell
35,243
-4,606
-12% -$424K 0.54% 48
2013
Q3
$3.46M Sell
39,849
-13,630
-25% -$1.22M 0.59% 51
2013
Q2
$4.59M Buy
+53,479
New +$4.54M 0.81% 43

Other funds holding JNJ

ARS Investment Partners's JNJ Position: Q2 2026 in Review

ARS Investment Partners increased its Johnson & Johnson (JNJ) stake by 0.76% in Q2 2026, buying an estimated $103K and bringing the position to 58,958 shares worth $15M. The position accounts for 0.65% of the portfolio, ranked #38.

ARS Investment Partners first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • ARS Investment Partners held 58,958 shares of Johnson & Johnson worth $15M as of Q2 2026.
  • ARS Investment Partners bought 443 Johnson & Johnson shares in Q2 2026, an estimated $103K.
  • Johnson & Johnson made up 0.65% of ARS Investment Partners's portfolio in Q2 2026, its #38 holding.
  • ARS Investment Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on ARS Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.